Announcements Trials
Browse Landscape

Status

Available 1Approved for marketing 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1204Observational 423Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Prostatic Neoplasms 16Neoplasms 11Neuroblastoma 9Lambert-Eaton Myasthenic Syndrome 7Recurrence 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Multiple Myeloma 6Leukemia 6Carcinoma, Hepatocellular 6Pheochromocytoma 5Lymphoma 5Leukemia, Myeloid, Acute 5Osteosarcoma 4Neuroendocrine Tumors 4Myelodysplastic Syndromes 4Liver Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Glioblastoma 4Sarcoma 3Precancerous Conditions 3Paraganglioma 3Pancreatic Neoplasms 3Neuroectodermal Tumors, Primitive 3Insulinoma 3Immunologic Deficiency Syndromes 3Hematologic Neoplasms 3Glioma 3Carcinoid Tumor 3Breast Neoplasms 3Sarcoma, Ewing 2

Interventions

Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Expanded_access × Colonic Neoplasms × Clear all
NCT01480128 2020-06-19

SIMPLE

The Catholic University of Korea

Approved for marketing
Gastrointestinal

Colonic Neoplasms

NCT01267461 2012-08-10

Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells

Meir Medical Center

Available
GastrointestinalGynecologic

Colonic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡